评估[18F]Bavarostat用于HDAC6 PET成像的重测重现性
本研究在6名健康参与者中评估[18F]Bavarostat PET显像定量组蛋白去乙酰化酶6(HDAC6)的重测重现性,两次扫描间隔28±12天(14-43天,n=6),每次扫描120分钟。MA1模型(t*=40分钟)与2TC模型一致性好,各脑区VT的个体绝对重测变异度(aTRV)为2%至9%,作者认为一个月扫描间隔的重测变异度结果良好,与已报道值相当。
要点
- 6名参与者两次[18F]Bavarostat PET扫描间隔28±12天(14-43天,n=6),每次120分钟。
- MA1模型(t*=40分钟)与2TC模型一致性好(MA1 VT=0.98×2TC VT+0.48,偏倚-0.1%),1TC低估VT 5.1%。
- 各脑区VT个体aTRV为2%至9%;100至120分钟扫描时长结果最一致,较小脑区(如杏仁核)需要更长扫描。
核心结论
- [18F]Bavarostat VT值在一个月扫描间隔下的重测变异度结果良好,与已报道值相当。
研究设计与样本
- 6名参与者(3男/3女)接受两次[18F]Bavarostat PET/CT扫描,每次120分钟,使用4环Biograph mCT PET/CT扫描仪,两次扫描间隔28±12天(14-43天,n=6)。
- 采集动脉血样行代谢物分析以获取输入函数,对15个感兴趣脑区生成时间-活性曲线,采用1TC、2TC和MA1模型进行动力学分析以定量VT并计算aTRV。
主要发现
- MA1模型(t*=40分钟)可充分描述各脑区时间-活性曲线,产生稳定动力学参数,与2TC一致性好(MA1 VT=0.98×2TC VT+0.48,偏倚-0.1%),而1TC低估VT 5.1%。
- 各脑区VT值分布相对均匀,杏仁核最高,半卵圆中心最低。
- 个体aTRV值为2%至9%。
- 100至120分钟扫描时长提供最一致结果,在所有测试t*值下偏倚最小且aTRV可接受;90分钟扫描(t*=10或20分钟)在扫描时间与aTRV间取得平衡,但最佳参数因脑区而异;较小脑区(如杏仁核)需要更长扫描以实现可靠VT定量。
关键数值与推荐
- MA1模型(t*=40分钟)与2TC模型的一致性关系为MA1 VT=0.98×2TC VT+0.48,偏倚-0.1%。
- 1TC模型低估VT 5.1%。
- 个体aTRV范围为2%至9%。
- 100至120分钟扫描时长在所有测试t*值下偏倚最小且aTRV可接受。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Histone deacetylase 6 (HDAC6) is an enzyme pivotal for gene regulation, influencing cellular pathways through protein deacetylation. HDAC6 is a potential therapeutic target in diseases such as cancer and neurodegenerative disorders. Koole et al. investigated brain binding of [18F]Bavarostat, an HDAC6 inhibitor, in healthy participants, revealing an absolute test-retest variability (aTRV) of 7.7% (n = 4) for the distribution volume (VT) with a 1-day interscan interval. This study aims to evaluate test-retest reproducibility with a more extended interscan interval. RESULTS: Six participants (3 M/3F) underwent a test-retest scan, each lasting for 120 min using a 4-ring Biograph mCT PET/CT scanner. Arterial blood sampling and metabolite analysis were performed to derive the input function. The two scans were 28 ± 12 days apart (14-43 days, n = 6). Regional time-activity curves (TACs) were generated for 15 regions of interest (ROIs). Kinetic analysis of the 120-min TACs was performed using one-tissue and two-tissue compartment models (1TC, 2TC) and multilinear analysis-1 (MA1) to quantify VT values and compute absolute test-retest variability (aTRV). The effects of scan duration (60 to 120 min) and MA1 t* setting on aTRV and bias were investigated. Careful analysis of the plasma HPLC data was needed since metabolites eluted close in time to the parent. The MA1 model (t* = 40 min) adequately described regional TACs and produced stable kinetic parameters with good agreement to 2TC (MA1 VT=0.98 × 2TC VT + 0.48, bias: -0.1%) while 1TC underestimated VT by 5.1%. Regional VT values exhibited a relatively uniform pattern, highest in the amygdala and lowest in the centrum semiovale. Individual aTRV values ranged from 2 to 9%. Scan durations between 100 and 120 min provided the most consistent results, with minimal bias and acceptable aTRV across all tested t* values. Although a 90-minute scan with t*=10 or 20-minute balanced scan time and aTRV, optimal parameters varied by brain region. Smaller regions (e.g., amygdala) required longer scans to achieve reliable VT quantification. CONCLUSIONS: The test-retest variability of [18F]Bavarostat VT values demonstrated favorable results for a one-month scan interval, comparable to the reported values.
引用
- Naganawa M, Zheng MQ, Gallezot JD, et al. Assessment of test-retest reproducibility by [18F]Bavarostat for PET imaging of HDAC6. EJNMMI Res. 2025. PMID: 40542929. doi:10.1186/s13550-025-01268-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。